• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Studies on peptides. CXXIII. Preparations of nine peptide fragments for the synthesis of human corticotropin releasing factor (hCRF).

作者信息

Fujii N, Nomizu M, Akaji K, Shimokura M, Katakura S, Yajima H

出版信息

Chem Pharm Bull (Tokyo). 1984 Dec;32(12):4786-96. doi: 10.1248/cpb.32.4786.

DOI:10.1248/cpb.32.4786
PMID:6335979
Abstract
摘要

相似文献

1
Studies on peptides. CXXIII. Preparations of nine peptide fragments for the synthesis of human corticotropin releasing factor (hCRF).
Chem Pharm Bull (Tokyo). 1984 Dec;32(12):4786-96. doi: 10.1248/cpb.32.4786.
2
Studies on peptides. CXXIV. Solution synthesis of the hentetracontapeptide amide corresponding to the entire amino acid sequence of human corticotropin releasing factor (hCRF).
Chem Pharm Bull (Tokyo). 1984 Dec;32(12):4797-805. doi: 10.1248/cpb.32.4797.
3
An optimized solid phase synthesis strategy--including on-resin lactamization--of astressin, its retro-, inverso-, and retro-inverso isomers as corticotropin releasing factor antagonists.
Biopolymers. 2002 Feb;63(2):141-9. doi: 10.1002/bip.10052.
4
Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.在大鼠体内作用持续时间延长的促肾上腺皮质激素释放因子拮抗剂（促肾上腺皮质激素释放因子拮抗剂）类似物。
J Med Chem. 1998 Dec 3;41(25):5012-9. doi: 10.1021/jm980426c.
5
Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.具有i-(i+3) 谷氨酸-Xaa-DXbb-赖氨酸桥的受限促肾上腺皮质激素释放因子 (CRF) 激动剂和拮抗剂。
J Med Chem. 1998 Dec 3;41(25):5002-11. doi: 10.1021/jm980350k.
6
Studies on peptides. CLIII. Application of the hard-acid deprotecting procedure to the synthesis of ovine corticotropin releasing factor (oCRF).
Chem Pharm Bull (Tokyo). 1987 Sep;35(9):3859-65. doi: 10.1248/cpb.35.3859.
7
Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat.在大鼠体内作用持续时间长的约束性促肾上腺皮质激素释放因子拮抗剂（阿斯特辛类似物）
J Med Chem. 1999 Aug 12;42(16):3175-82. doi: 10.1021/jm9902133.
8
Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.人类和两栖类促肾上腺皮质激素释放因子1型（CRF(1)）受体的结合差异：介导高亲和力阿斯特辛结合和功能拮抗作用的氨基酸鉴定
Regul Pept. 2004 May 15;118(3):165-73. doi: 10.1016/j.regpep.2003.12.012.
9
Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides.促肾上腺皮质激素释放因子的决定因素。促肾上腺皮质激素释放因子相关肽的受体选择性。
J Med Chem. 2004 Jun 17;47(13):3450-4. doi: 10.1021/jm049883l.
10
Isolation, structural elucidation and synthesis of a tetradecapeptide with in vitro ACTH-releasing activity corresponding to residues 33-46 of the alpha-chain of porcine hemoglobin.
Biochem Biophys Res Commun. 1978 May 30;82(2):582-8. doi: 10.1016/0006-291x(78)90914-2.